[A new method in the treatment of migraine using anticholinesterase drugs (clinical observations)].
D000109:Acetylcholine / Q000494:pharmacology; D000553:Ambulatory Care; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D005500:Follow-Up Studies; D005702:Galantamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009388:Neostigmine / Q000009:adverse effects / Q000627:therapeutic use*; D012702:Serotonin Antagonists
D002800:Cholinesterase Inhibitors; D012702:Serotonin Antagonists; D005702:Galantamine; D009388:Neostigmine; D000109:Acetylcholine
Nouvelle méthode de traitement de la migraine au moyen de médicaments anticholinestérasiques (observations cliniques)